BioCryst Pharmaceuticals Aktie

Kaufen
Verkaufen
7,04 EUR -0,18 EUR -2,44 %
7,57 USD +0,18 USD +2,44 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 1,5 Mrd. EUR

Div. Rendite 0,00%

WKN 896047

ISIN US09058V1035

Symbol BCRX


BioCryst Pharmaceuticals Aktie Analyse

02.01.18 BioCryst Pharmaceuticals Outperform RBC Capital Markets
21.04.15 BioCryst Pharmaceuticals Outperform FBR Capital
02.12.09 BioCryst Pharmaceuticals market outperform JMP Securities LLC
14.10.09 BioCryst Pharmaceuticals market outperform JMP Securities LLC
13.08.07 BioCryst Pharmaceuticals above average Caris & Company, Inc.
26.06.07 BioCryst Pharmaceuticals above average Caris & Company
13.02.07 BioCryst Pharmaceuticals Biotech-Report
26.06.06 BioCryst Pharmaceuticals stark kaufen Jaindl & Mautz
14.06.06 BioCryst Pharmaceuticals Above Average Caris & Company
10.03.06 BioCryst Pharmaceuticals buy CE Unterberg, Towbin
20.02.06 BioCryst Pharmaceuticals buy CE Unterberg, Towbin
11.08.05 BioCryst Pharmaceuticals Buy Wedbush Morgan